BioNexus Gene Lab's change in inventory for the quarter that ended in Mar. 2024 was $0.06 Mil. It means BioNexus Gene Lab's inventory
declined by $0.06 Mil
from Dec. 2023 to Mar. 2024 .
BioNexus Gene Lab's change in inventory for the fiscal year that ended in Dec. 2023 was $-0.16 Mil. It means BioNexus Gene Lab's inventory
increased by $0.16 Mil
from Dec. 2022 to Dec. 2023 .
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
BioNexus Gene Lab's Days Inventory for the quarter that ended in Mar. 2024 was 50.10.
Inventory Turnover measures how fast the company turns over its inventory within a year.
BioNexus Gene Lab's Inventory Turnover for the quarter that ended in Mar. 2024 was 1.82.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
BioNexus Gene Lab's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 0.46.
BioNexus Gene Lab Change In Inventory Historical Data
The historical data trend for BioNexus Gene Lab's Change In Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.
Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.18 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioNexus Gene Lab (NAS:BGLC) Change In Inventory Explanation
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
BioNexus Gene Lab's Days Inventory for the quarter that ended in is calculated as:
3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
BioNexus Gene Lab's Inventory to Revenue for the quarter that ended in Mar. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioNexus Gene Lab Change In Inventory Related Terms
Thank you for viewing the detailed overview of BioNexus Gene Lab's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
BioNexus Gene Lab (BioNexus Gene Lab) Business Description
BioNexus Gene Lab Corp is an emerging molecular diagnostics company focused on the application of functional genomics to enable early diagnosis and personalized health management. It focuses on developing and marketing safe, effective, and non-invasive blood tests for the early detection of diseases. The company's non-invasive blood tests analyze changes in ribonucleic acid (or RNA) to detect the potentiality of 11 different diseases. These diseases include eight cancers (nasopharyngeal, lung, liver, stomach, breast, cervical, prostate, and colon), two bowel diseases (colitis and Crohn), and osteoarthritis.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BGLC has been successfully added to your 